N

NervGen Pharma Corp.
D

NGEN

1.99500
USD
-0.06
(-2.68%)
مغلق
حجم التداول
13,400
الربح لكل سهم
-1
العائد الربحي
-
P/E
-4
حجم السوق
211,875,256
المقالات
المزيد

العنوان: NervGen Pharma Corp.

القطاع: Healthcare
الصناعة: Biotechnology
NervGen Pharma Corp is a clinical-stage biopharmaceutical company developing first-in-class neuroreparative therapeutics for spinal cord injury and other traumatic and neurologic conditions. The Company's principal business activity is thediscovery, development and commercialization of neuroreparative therapeutics for spinal cord injury (SCI) and other neurotraumatic and neurologic conditions. NervGen's initial target indication is SCI. The company's pipeline products include NVG-291 and NVG-300.